PP
MLNT

Paloma Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Paloma Partners’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,800
Closed -$205K – 2000
2019
Q2 		$205K Buy
+30,800
New +$205K ﹤0.01% 1288